| |
| |
|
| Insider
Information: |
Hoberman Kenneth |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
297,825 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,154,767 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
297,825 |
|
|
| Total
Value |
$4,154,767 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
5.0
|
| Percentage
Gain/Loss : |
0.0%
|
 402.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stemline Therapeutics Inc |
STML |
Chief Operating Officer |
2020-06-10 |
0 |
|
0 |
Premium* |
|
|
TG Therapeutics Inc |
TGTX |
Director |
2023-09-28 |
242,685 |
|
0 |
Premium* |
|
|
Nuvectis Pharma, Inc. |
NVCT |
Director |
2022-05-12 |
55,140 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
71 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVCT |
Nuvectis Pharma, Inc. |
Director |
– • – |
2022-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
49,140 |
|
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Director |
– • – |
2022-05-12 |
4 |
B |
$17.40 |
$104,400 |
D/D |
6,000 |
55,140 |
2.39 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating OfficerOfficer |
• – – |
2013-03-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
19,288 |
|
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2013-11-22 |
4 |
S |
$20.14 |
$232,073 |
D/D |
(11,523) |
42,765 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2013-11-22 |
4 |
OE |
$1.11 |
$38,850 |
D/D |
35,000 |
54,288 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2013-11-25 |
4 |
S |
$21.94 |
$314,839 |
D/D |
(14,350) |
65,415 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2013-11-25 |
4 |
OE |
$1.11 |
$41,070 |
D/D |
37,000 |
79,765 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2013-11-26 |
4 |
S |
$21.27 |
$66,873 |
D/D |
(3,144) |
69,238 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2013-11-26 |
4 |
OE |
$1.11 |
$7,733 |
D/D |
6,967 |
72,382 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2013-11-27 |
4 |
S |
$19.91 |
$306,833 |
D/D |
(15,411) |
87,800 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2013-11-27 |
4 |
OE |
$1.11 |
$37,710 |
D/D |
33,973 |
103,211 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2014-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
14,985 |
102,785 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2014-05-21 |
4 |
S |
$13.32 |
$203,130 |
D/D |
(15,250) |
87,535 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2014-09-02 |
4 |
B |
$10.99 |
$21,975 |
D/D |
2,000 |
89,535 |
2.74 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2015-02-18 |
4 |
S |
$14.02 |
$22,334 |
D/D |
(1,593) |
87,942 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2015-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
24,379 |
112,321 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2015-03-19 |
4 |
S |
$16.43 |
$284,354 |
D/D |
(17,307) |
122,119 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2015-03-19 |
4 |
OE |
$4.09 |
$110,859 |
D/D |
27,105 |
139,426 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2015-12-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
60,000 |
62,119 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2016-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
212,562 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2016-02-17 |
4 |
S |
$4.54 |
$6,824 |
D/D |
(1,503) |
211,059 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2016-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
87,985 |
299,044 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2016-03-08 |
4 |
S |
$5.34 |
$12,880 |
D/D |
(2,412) |
297,392 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-01-10 |
4 |
S |
$13.82 |
$125,900 |
D/D |
(9,110) |
289,190 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-02-16 |
4 |
S |
$6.42 |
$9,681 |
D/D |
(1,508) |
287,682 |
0 |
- |
|
71 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
